Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Indonesian Journal of Pharmaceutical Education
Rilawati, Fentyana
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Materials Science & Nanotechnology Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Effectiveness of Anticoagulants in Reducing D-Dimer Levels in COVID-19 Patients: A Retrospective Study Winduhani Astuti, Lelly; Fajriah, Shofiatul; Rilawati, Fentyana; Istiqomah, Nurul
Indonesian Journal of Pharmaceutical Education Vol 5, No 1 (2025): January–April 2025
Publisher : Jurusan Farmasi Universitas Negeri Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37311/ijpe.v5i1.30233

Abstract

Coronavirus Disease 2019 (COVID-19) is an acute respiratory infection caused by the SARS-CoV-2 virus. SARS-CoV-2 infection is often associated with blood clotting disorders, both at the microvascular and macrovascular levels due to hypercoagulability. Changes in blood clotting status are indicated by high levels of D-dimer and fibrinogen. The study aimed to evaluate the effectiveness of three anticoagulant therapies in reducing D-dimer levels in COVID-19 patients. The research employed an observational analytical method with a retrospective cross-sectional study design. The results showed significant differences in D-dimer reduction among the treatment groups. The mean reductions in D-dimer levels for patients receiving anticoagulant therapy with heparin, enoxaparin, and fondaparinux were 1.397 µg/L, 2.607 µg/L, and 2.855 µg/L, respectively. Statistical analysis indicated a significant difference among the groups (P 0.05). It can be concluded that fondaparinux demonstrated a greater reduction in D-dimer levels compared to heparin and enoxaparin.
Co-Authors Fajriah, Shofiatul Nurul Istiqomah Winduhani Astuti, Lelly